Search Results 161-170 of 20698 for ulcerative colitis
This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...
The purpose of this study is to evaluate safety and efficacy of risankizumab in subjects with ulcerative colitis (UC) in subjects who responded to induction ...
Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...
... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...
Description. Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and ...
The purpose of this study is to assess the effectiveness and safety of SER-287 in adults with active mild-to-moderate ulcerative colitis. Participation ...
Inflammatory bowel disease (IBD), which consists of Crohn's disease and ulcerative colitis, can be a frustrating diagnosis to deal with. In general, there ...
People with inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are at increased risk of developing colorectal cancer compared ...
... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
Olsalazine is used in patients who have had ulcerative colitis to prevent the condition from occurring again. It works inside the bowel by helping to reduce ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.